Radiopharm Theranostics Ltd (RADX) stock
RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
$0.67−0.10 (-12.58%)
Close on Nov 17, 2026Market cap $7.93MP/E –Yield –
Radiopharm Theranostics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2026 it was $2.77M, down 23.8% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $2.77M | -23.8% |
| FY2025 | Jun 30, 2025 | $3.63M | +1114.3% |
| FY2024 | Jun 30, 2024 | $299.23K | +2.3% |
| FY2023 | Jun 30, 2023 | $292.36K | – |
See a number that looks wrong?